PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $275,268 | -29.7% | 44,832 | -28.3% | 0.00% | -50.0% |
| Q2 2023 | $391,438 | +63.9% | 62,530 | +24.9% | 0.00% | +100.0% |
| Q1 2023 | $238,772 | -46.2% | 50,057 | -1.8% | 0.00% | -50.0% |
| Q4 2022 | $443,439 | +17.3% | 50,970 | +60.3% | 0.00% | 0.0% |
| Q3 2022 | $378,000 | -15.6% | 31,790 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $448,000 | +10.6% | 31,470 | +61.8% | 0.00% | 0.0% |
| Q1 2022 | $405,000 | +39.7% | 19,450 | +55.0% | 0.00% | +100.0% |
| Q4 2021 | $290,000 | -22.5% | 12,550 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $374,000 | – | 12,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,869,911 | $115,323,000 | 47.76% |
| Euclidean Capital LLC | 2,769,813 | $82,540,000 | 40.12% |
| Logos Global Management LP | 1,400,000 | $41,720,000 | 3.01% |
| Orbimed Advisors | 7,330,423 | $218,447,000 | 2.40% |
| Boxer Capital, LLC | 2,268,236 | $67,593,000 | 2.36% |
| PERSONAL CFO SOLUTIONS, LLC | 355,342 | $10,589,000 | 2.17% |
| Asymmetry Capital Management, L.P. | 100,882 | $3,006,000 | 1.81% |
| Avoro Capital Advisors LLC | 2,925,000 | $87,165,000 | 1.37% |
| COMMODORE CAPITAL LP | 125,000 | $3,725,000 | 0.98% |
| HighVista Strategies LLC | 39,777 | $1,185,000 | 0.78% |